HOXB5 and hepatocellular carcinoma: Moreover, Kaplan-Meier exhibited that positive co-expression of HOXB5/FGF19 or HOXB5/FGFR4 predicted highest recurrence rate and shortest survival time of HCC patients (Figure S2F-G).